Study tracks couples after failed embryo genetic testing
NCT ID NCT07371312
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 900 couples in Paris who tried preimplantation genetic diagnosis (PGD) to avoid passing on a severe genetic disease but did not have a baby from it. Researchers want to know how many later have a healthy child naturally, through other treatments, or decide to stop trying. The goal is to better understand and support couples facing this difficult situation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 900 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Women belonging to couples managed for preimplantation genetic diagnosis (PGD) at the Paris PGD center (Hôpital Antoine Béclère - Necker, AP-HP) between 2006 and 2022, whose PGD care was discontinued without resulting in a live birth. Couples are identified from an institutional PGD database. All PGD indications are eligible.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Woman belonging to a couple who initiated at least one ovarian stimulation cycle for IVF (± ICSI) with preimplantation genetic diagnosis (PGD). * No further PGD-related procedures (oocyte retrieval or embryo transfer) performed in the center after December 31, 2022. * No live-born child resulting from PGD care. * Woman who expressed her free and informed non-opposition to participation. Exclusion Criteria: * One or more live-born children resulting from PGD care in the center. * PGD involving gamete donation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Infertility are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hôpital Antoine Béclère
RECRUITINGClamart, 92140, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The hidden handshake that decides whether an embryo implants
- Do infertility treatments leave a metabolic mark on children?
- Could a Woman's biological clock also predict her Heart's future?
- Sperm sorting showdown: can a microchip pick the best sperm for pregnancy?
- Could your genes predict when fertility fades?
- Can virtual reality goggles take the sting out of a fertility procedure?